SLABÝ, Ondřej, Josef SROVNAL, Lenka RADOVÁ, Jan GREGAR, Jaroslav JURÁČEK, Pavla LUŽNÁ, Marek SVOBODA, Marian HAJDÚCH and Jiří EHRAMANN. Dynamic changes in microRNA expression profiles reflect progression of Barrett's esophagus to esophageal adenocarcinoma. Carcinogenesis. Oxford: Oxford University Press, 2015, vol. 36, No 5, p. 521-527. ISSN 0143-3334. Available from: https://dx.doi.org/10.1093/carcin/bgv023.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Dynamic changes in microRNA expression profiles reflect progression of Barrett's esophagus to esophageal adenocarcinoma
Authors SLABÝ, Ondřej (203 Czech Republic, guarantor, belonging to the institution), Josef SROVNAL (203 Czech Republic), Lenka RADOVÁ (203 Czech Republic, belonging to the institution), Jan GREGAR (203 Czech Republic), Jaroslav JURÁČEK (203 Czech Republic, belonging to the institution), Pavla LUŽNÁ (203 Czech Republic), Marek SVOBODA (203 Czech Republic, belonging to the institution), Marian HAJDÚCH (203 Czech Republic) and Jiří EHRAMANN (203 Czech Republic).
Edition Carcinogenesis, Oxford, Oxford University Press, 2015, 0143-3334.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.874
RIV identification code RIV/00216224:14740/15:00080394
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1093/carcin/bgv023
UT WoS 000354746400002
Keywords in English microRNA; Barrett's esophagus; esophageal carcinoma
Tags rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Eva Špillingová, učo 110713. Changed: 23/3/2016 11:23.
Abstract
Esophageal adenocarcinoma (EAC) is highly aggressive malignancy that frequently develops from Barrett's esophagus (BE), a premalignant pathologic change occurring in the lower end of the esophagus. MicroRNAs (miRNAs) are small, non-coding RNAs that function as posttranscriptional regulators of gene expression and were repeatedly proved to play key roles in pathogenesis of BE as well as EAC. In our study, we used Affymetrix GeneChip miRNA arrays to obtain miRNA expression profiles in total of 119 tissue samples [24 normal esophageal mucosa (EM), 60 BE and 35 EAC]. We identified a number of miRNAs, that showed altered expression progressively in sequence EM, BE and EAC, including for instance miR-21, miR-25, miR-194 and miR-196a with increasing levels (P < 0.0015) and miR-203, miR-205, miR-210 and miR-378 with decreasing levels (P < 0.0001). The subsequent analysis revealed four diagnostic miRNA signatures enabling to distinguish EM and BE [12 miRNAs, area under curve (AUC) = 0.971], EM and EAC (13 miRNAs, AUC = 1.0), BE without and BE with dysplasia (21 miRNAs, AUC = 0.856) and BE without dysplastic changes and BE with dysplasia together with EAC (2 miRNAs, AUC = 0.886). We suggest that miRNA expression profiling expands current knowledge in molecular pathology of Barrett's-based carcinogenesis and enables identification of molecular biomarkers for early detection of BE dysplasia and progression to EAC.
Links
ED1.1.00/02.0068, research and development projectName: CEITEC - central european institute of technology
TE02000058, research and development projectName: Centrum kompetence pro molekulární diagnostiku a personalizovanou medicínu (Acronym: MOLDIMED)
Investor: Technology Agency of the Czech Republic
PrintDisplayed: 8/10/2024 19:46